662-SC291低免疫CD19 CAR T细胞临床免疫逃避研究 episode artwork

EPISODE · Mar 19, 2026 · 14 MIN

662-SC291低免疫CD19 CAR T细胞临床免疫逃避研究

from 聊聊Sci

这份报告研究了名为 SC291 的新型通用型 CD19 CAR T 细胞在癌症和自身免疫病患者中的临床表现。该细胞经过低免疫(HIP)基因编辑,通过敲除 HLA 并过表达 CD47 来逃避人体的免疫排斥。临床数据显示,尽管患者会对未完全编辑的细胞产生攻击,但完全编辑的 HIP CAR T 细胞在所有患者中均能成功避开 T 细胞、NK 细胞及抗体的检测与杀伤。此外,研究发现患者体内若不产生针对 HLA 的特定抗体,可作为深层组织 B 细胞耗竭的有效监测指标。这些发现证实了 HIP 技术在开发无需严格免疫抑制的通用型细胞疗法方面的可靠潜力。References: Hu X, Beauchesne P, Wang C, et al. Hypoimmune CD19 CAR T cells evade allorejection in patients with cancer and autoimmune disease[J]. Cell Stem Cell, 2025, 32(9): 1356-1368. e4.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Mar 19, 2026

Embed this episode

Ready to play

662-SC291低免疫CD19 CAR T细胞临床免疫逃避研究

0:00 14:05

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 14 minutes long.

When was this 聊聊Sci episode published?

This episode was published on March 19, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!